Just for the holiday season, Pfizer (
) and GlaxoSmithKline () said that they sell an additional 360 million doses of vaccine pneumonia of the global organization of health care at a reduced $ 3. 50 a dose. This increases the combined 600000000 dose they are committed under the previous year
Reuters. Global Alliance for Vaccines and Immunization purchases dose is divided equally between Synflorix company Pfizer Prevenar company GlaxoSmithKline. Both corporations will deliver vaccines through 2023. Global Alliance for Vaccines and Immunization, or HAVI, raised $ 4. 3 billion commitment from donors in June to help fund its efforts to immunize children against pneumococcal infection which kills over 500,000 children annually, mostly in developing countries, and causes pneumonia, meningitis and sepsis. HAVI hopes to strattera without prescritpion prevent 7000000 people in 2030
Reuters said. Large orders have helped keep prices down
notes Reuters. Pfizer and GSK will receive $ 7 per dose for the first 20% of vaccines and $ 3. 50 other. It is unclear which vaccine will be clean at full price. At least, Pfizer, however, $ 3. 50 price is more than 90% cheaper than the market price in some industrialized countries, said company spokesman
Reuters. - Here's Reuters Related articles
No comments:
Post a Comment